Skip to main content
. 2023 Apr 27;11:923319. doi: 10.3389/fpubh.2023.923319

Table 3.

Univariate and multivariate analysis of factors associated with treatment success.

Characteristic Univariate analysis Multivariate analysis
Hazard ratio (95% CI) p-value Hazard ratio (95% CI)a p-value
Sex
Female 1.00 1.00
Male 0.95 (0.73, 1.24) 0.710 0.89 (0.67, 1.17) 0.4
Age, years
18–29 1.00 1.00
30–44 0.69 (0.51, 0.95) 0.023 0.62 (0.44, 0.88) 0.007
45–59 0.98 (0.66, 1.47) 0.936 0.94 (0.61, 1.44) 0.8
> = 60 0.87 (0.61, 1.24) 0.437 0.91 (0.59, 1.40) 0.7
Migrant
No 1.00
Yes 1.09 (0.83, 1.43) 0.542
Completed high school
No 1.00
Yes 0.90 (0.70, 1.16) 0.428
Marital status
Married 1.00
Single 1.16 (0.90, 1.50) 0.261
Occupation
Student or employed 1.00
Unemployed or retired 1.04 (0.77, 1.40) 0.788
Insured
No 1.00
Yes 1.00 (0.77, 1.29) 0.975
Reimbursement policy covered
No 1.00 1.00
Yes 1.16 (0.90, 1.49) 0.263 1.10 (0.82, 1.48) 0.5
Number of family members 0.96 (0.88, 1.05) 0.347
Bacteriologically confirmed
No 1.00 1.00
Yes 0.82 (0.63, 1.06) 0.128 0.75 (0.57, 0.99) 0.044
Cavity
No 1.00 1.00
Yes 0.71 (0.49, 1.03) 0.069 0.68 (0.46, 1.00) 0.050
Combined with EPTB
No 1.00 1.00
Yes 0.61 (0.43, 0.87) 0.006 0.51 (0.35, 0.74) <0.001
Type 2 diabetes
No 1.00 1.00
Yes 1.05 (0.58, 1.93) 0.863 1.02 (0.54, 1.91) >0.9
Group
Standard care 1.00 1.00
Reminder app 1.50 (1.10, 2.06) 0.010 1.58 (1.12, 2.22) 0.009
Smart pillbox 1.42 (1.05, 1.93) 0.023 1.63 (1.16, 2.30) 0.005
a

Adjusted for potentially confounding factors of sex, age, reimbursement policy coverage, bacteriological confirmation, cavity, combined with EPTB, and type 2 diabetes comorbidity.

EPTB, extrapulmonary TB.